These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26448449)

  • 1. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
    Zhu J; Wu J; Yin H; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.
    Yin H; Tan Z; Wu J; Zhu J; Shedden KA; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4876-84. PubMed ID: 26403951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
    Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
    J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
    Zhang S; Shu H; Luo K; Kang X; Zhang Y; Lu H; Liu Y
    Mol Biosyst; 2011 May; 7(5):1621-8. PubMed ID: 21380457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Peta V; Zhu J; Lubman DM; Huguet S; Imbert-Bismutd F; Bolbach G; Clodic G; Matheron L; Ngo Y; Raluca P; Housset C; Rezai K; Poynard T;
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):681-691. PubMed ID: 31964615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.
    Yin H; Lin Z; Nie S; Wu J; Tan Z; Zhu J; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2887-96. PubMed ID: 24799124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
    Zhang S; Jiang K; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
    Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.
    Pompach P; Brnakova Z; Sanda M; Wu J; Edwards N; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1281-93. PubMed ID: 23389049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
    Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.
    Lin Z; Simeone DM; Anderson MA; Brand RE; Xie X; Shedden KA; Ruffin MT; Lubman DM
    J Proteome Res; 2011 May; 10(5):2602-11. PubMed ID: 21417406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
    Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
    Tanabe K; Kitagawa K; Kojima N; Iijima S
    J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
    Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
    Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
    Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
    Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
    Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.